Bristlecone Advisors’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $71.9K | Sell |
|
|||||
|
2024
Q4 | $198K | Hold |
|
|||||
|
2024
Q3 | $151K | Buy |
|
|||||
|
2024
Q2 | $226K | Hold |
|
|||||
|
2024
Q1 | $234K | Hold |
|
|||||
|
2023
Q4 | $207K | Hold |
|
|||||
|
2023
Q3 | $172K | Hold |
|
|||||
|
2023
Q2 | $252K | Hold |
|
|||||
|
2023
Q1 | $213K | Sell |
|
|||||
|
2022
Q4 | $2.21M | Sell |
|
|||||
|
2022
Q3 | $2.08M | Hold |
|
|||||
|
2022
Q2 | $2.14M | Sell |
|
|||||
|
2022
Q1 | $10.3M | Hold |
|
|||||
|
2021
Q4 | $9.92M | Hold |
|
|||||
|
2021
Q3 | $7.14M | Hold |
|
|||||
|
2021
Q2 | $7.8M | Buy |
|